コンテンツへスキップ
Merck
  • A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90.

A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90.

Autophagy (2015-02-24)
Christopher N J Young, Anthony Sinadinos, Alexis Lefebvre, Philippe Chan, Stephen Arkle, David Vaudry, Dariusz C Gorecki
要旨

P2RX7 is an ATP-gated ion channel, which can also exhibit an open state with a considerably wider permeation. However, the functional significance of the movement of molecules through the large pore (LP) and the intracellular signaling events involved are not known. Here, analyzing the consequences of P2RX7 activation in primary myoblasts and myotubes from the Dmd(mdx) mouse model of Duchenne muscular dystrophy, we found ATP-induced P2RX7-dependent autophagic flux, leading to CASP3-CASP7-independent cell death. P2RX7-evoked autophagy was triggered by LP formation but not Ca(2+) influx or MAPK1-MAPK3 phosphorylation, 2 canonical P2RX7-evoked signals. Phosphoproteomics, protein expression inference and signaling pathway prediction analysis of P2RX7 signaling mediators pointed to HSPA2 and HSP90 proteins. Indeed, specific HSP90 inhibitors prevented LP formation, LC3-II accumulation, and cell death in myoblasts and myotubes but not in macrophages. Pharmacological blockade or genetic ablation of p2rx7 also proved protective against ATP-induced death of muscle cells, as did inhibition of autophagy with 3-MA. The functional significance of the P2RX7 LP is one of the great unknowns of purinergic signaling. Our data demonstrate a novel outcome--autophagy--and show that molecules entering through the LP can be targeted to phagophores. Moreover, we show that in muscles but not in macrophages, autophagy is needed for the formation of this LP. Given that P2RX7-dependent LP and HSP90 are critically interacting in the ATP-evoked autophagic death of dystrophic muscles, treatments targeting this axis could be of therapeutic benefit in this debilitating and incurable form of muscular dystrophy.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ダルベッコリン酸緩衝生理食塩水, Modified, without calcium chloride and magnesium chloride, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
トリズマ® 塩基, Primary Standard and Buffer, ≥99.9% (titration), crystalline
Sigma-Aldrich
トリス(2-カルボキシエチル)ホスフィン 塩酸塩, powder
Sigma-Aldrich
L-グルタミン 溶液, 200 mM, solution, sterile-filtered, BioXtra, suitable for cell culture
Sigma-Aldrich
ヨードアセトアミド, BioUltra
Sigma-Aldrich
ジギトニン, Used as non-ionic detergent
Sigma-Aldrich
臭化エチジウム 溶液, BioReagent, for molecular biology, 10 mg/mL in H2O
Sigma-Aldrich
抗アクチン ウサギ宿主抗体, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
オルトバナジン酸ナトリウム, ≥90% (titration)
Sigma-Aldrich
抗LC3B ウサギ宿主抗体, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Supelco
ビシンコニン酸 溶液
Sigma-Aldrich
抗マウスIgG (全分子)-ペルオキシダーゼ ヤギ宿主抗体, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
抗GAPDH ウサギ宿主抗体, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
3-メチルアデニン, autophagy inhibitor
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
抗ウサギIgG (全分子)-ペルオキシダーゼ ヤギ宿主抗体, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
ルシファーイエローCH 二リチウム塩, fluorescent stain
Sigma-Aldrich
2′(3′)-O-(4-ベンゾイルベンゾイル)アデノシン 5′-三リン酸 トリエチルアンモニウム塩, ≥93%
Sigma-Aldrich
E-64d, protease inhibitor
Sigma-Aldrich
In vitro毒性アッセイキット(乳酸脱水素酵素ベース)
Sigma-Aldrich
テトラメチルローダミンエチルエステル過塩素酸塩, suitable for fluorescence, ≥90% (HPCE)